Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

Song Joon Young; Cheong Hee Jin; Lee Jacob; Woo Heung Jeong; Wie Seong-Heon; Lee Jin-Soo; Kim Shin Woo; Noh Ji Yun; Choi Won Suk; Kim Hun; Kim Kyung-Ho; Kim Woo Joo

首页> 外文期刊>Vaccine >Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

【24h】

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

机译：细胞培养灭活的三价流感疫苗（NBP607）的免疫原性和安全性：一项随机，双盲，多中心，3期临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Cell culture-derived influenza vaccines (CCIVs) have several important advantages over egg-based influenza vaccines, including shorter production time, better preservation of wild-type virus antigenicity and large-scale production capacity.

机译：背景：源自细胞培养的流感疫苗（CCIV）与基于蛋的流感疫苗相比具有几个重要优势，包括生产时间更短，野生型病毒抗原性的更好保存和大规模生产能力。

著录项

来源
《Vaccine》 |2015年第41期|共8页
作者
Song Joon Young; Cheong Hee Jin; Lee Jacob; Woo Heung Jeong; Wie Seong-Heon; Lee Jin-Soo; Kim Shin Woo; Noh Ji Yun; Choi Won Suk; Kim Hun; Kim Kyung-Ho; Kim Woo Joo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Influenza vaccines; Cell culture techniques; Influenza; Human; Vaccines; Inactivated;

机译：流感疫苗;细胞培养技术;流感;人类;疫苗;灭活;

相似文献

外文文献
中文文献
专利

1. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial [J] . Song Joon Young, Cheong Hee Jin, Lee Jacob, Vaccine . 2015,第41期

机译：细胞培养灭活的三价流感疫苗（NBP607）的免疫原性和安全性：一项随机，双盲，多中心，3期临床试验
2. Immunogenicity and safety of trivalent inactivated influenza vaccine: a randomized, double-blind, multi-center, phase 3 clinical trial in a vaccine-limited country. [J] . Song JY, Cheong HJ, Woo HJ, Journal of Korean medical science . 2011,第2期

机译：三价灭活流感疫苗的免疫原性和安全性：在疫苗有限的国家进行的一项随机，双盲，多中心，3期临床试验。
3. Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country [J] . Song Joon Young, Cheong Hee Jin, Woo Heung Jeong, Journal of Korean medical science. . 2011,第2期

机译：三价灭活流感疫苗的免疫原性和安全性：疫苗限制国家/地区的一项随机，双盲，多中心，三期临床试验。
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Efficacy of the Regular Trivalent Inactivated Influenza Vaccine in an Aging Veteran Population with Pre-Existing Conditions. [D] . Crickmer, Amy. 2013

机译：常规三价灭活流感疫苗在老龄老龄人口中的疗效。
6. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects [O] . Won Suk Choi, Ji Yun Noh, Joon Young Song, 2018

机译：细胞培养灭活的四价流感疫苗（NBP607-QIV）的免疫原性和安全性：成人和老年受试者的一项随机，双盲，多中心，III期临床试验
7. Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country [O] . Song, Joon Young, Cheong, Hee Jin, Woo, Heung Jeong, 2011

机译：三价灭活流感疫苗的免疫原性和安全性：在疫苗限制国家/地区进行的随机，双盲，多中心，3期临床试验
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅